Suchergebnisse - "Selkoe, Dennis"

PubPharm (717)

31

Identification of the Aβ37/42 peptide ratio in CSF as an improved Aβ biomarker for Alzheimer's disease

enthalten in: Alzheimer's & Dementia | 2023

von Liu, L. | Lauro, B. | He, A. | +7

32

Enriched environment enhances β‐adrenergic signaling to prevent microglia inflammation by amyloid‐β

enthalten in: EMBO Molecular Medicine | 2023

von Xu, H. | Rajsombath, M. | Weikop, P. | +1

33

Plasma NT1‐tau and Aβ42 correlate with age and cognitive function in two large Down syndrome cohorts

enthalten in: Alzheimer's & Dementia | 2023

von Stern, A. | Van Pelt, K. | Liu, L. | +10

34

Functional variations in gamma‐secretase processing of APP are critical determinants of the clinical, biomarker, and cognitive progression of autosomal dominant Alzheimer’s disease

enthalten in: Alzheimer's & Dementia | 2023

von Schultz, S. | Liu, L. | Schultz, A. | +24

35

Utilizing low‐volume PBMC samples from Alzheimer’s disease clinical research cohorts for immune cell RNA‐sequencing

enthalten in: Alzheimer's & Dementia | 2023

von Viera, A. | Bellier, J. | Runnels, A. | +12

36

Comparing the effectiveness of a brief observational study protocol versus a telephone call for Alzheimer’s disease prevention trial prescreening

enthalten in: Alzheimer's & Dementia | 2023

von Christiano, C. | Moreno, S. | Anzai, J. | +16

37

Dynamic reversibility of α‐synuclein serine‐129 phosphorylation is impaired in synucleinopathy models

enthalten in: EMBO reports | 2023

von Ramalingam, N. | Brontesi, L. | Jin, S. | +2

38

Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease : Two Phase 3 Randomized Placebo-Controlled Trials

enthalten in: JAMA neurology | 2022

von Ostrowitzki, S. | Bittner, T. | Sink, K. | +24

39

Aβ oligomers from human brain impair mossy fiber LTP in CA3 of hippocampus, but activating cAMP-PKA and cGMP-PKG prevents this

enthalten in: Neurobiology of disease | 2022

von Jin, S. | Liu, L. | Li, S. | +2

40

Unfairness to Patients With Alzheimer Disease in Medicare's Coverage of Antiamyloid Immunotherapy

enthalten in: JAMA neurology | 2022

von Stern, A. | Selkoe, D.